Adverum Biotechnologies Inc. (ADVM) NASDAQ
$10.19 (0.81) (-7.36%)
Market Cap: $2.11B
As of 04/24/24 04:00 PM EDT. Market closed.
Adverum Biotechnologies Inc. (ADVM)
NASDAQ
$10.19
(0.81) (-7.36%)
Market Cap: $2.11B
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. we are advancing the development of a robust pipeline of gene therapies that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (a1at) deficiency and hereditary angioedema (hae) as well as wet age-related macular degeneration (wamd). ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Leone Patterson
Full Time Employees
174
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Leone Patterson
Full Time Employees
174
CEO Compensation (Base)
$188,300
URL
Address
800 Saginaw Drive, California, Redwood City, 94063.
PRICE CHART FOR ADVERUM BIOTECHNOLOGIES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$11
Days Range
$10.19 - $11.10
52 week range
$7.10 - $29.70
Volume
404,696
Avg. Volume (30 days)
200,274
Market Cap
$2.11B
Dividend Yield
-
P/E
-
Shares Outstanding
207,549,152
Open
-
Previous Close
$11
Days Range
$10.19 - $11.10
52 week range
$7.10 - $29.70
Volume
404,696
Avg. Volume (30 days)
200,274
Market Cap
$2.11B
Dividend Yield
-
P/E
-
Shares Outstanding
207,549,152
FINANCIAL STATEMENTS FOR ADVERUM BIOTECHNOLOGIES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ADVERUM BIOTECHNOLOGIES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Scopa James Paul | Director | Feb 07, 2024 | Buy | $1.35 | 100,000 | 135,000 | 100,000 | Feb 09, 2024, 05:51 PM |
| Lupher, Jr. Mark L. | Director | Feb 07, 2024 | Buy | $1.35 | 130,000 | 175,500 | 130,000 | Feb 09, 2024, 05:50 PM |
| Seyedkazemi Setareh | Chief Development Officer | Sep 15, 2023 | Sale | $1.52 | 6,201 | 9,429 | 47,804 | Sep 18, 2023, 06:54 PM |
| Rubinstein Linda M | Chief Financial Officer | Jun 07, 2023 | Buy | $1.45 | 100,000 | 145,490 | 100,000 | Jun 09, 2023, 04:26 PM |
| Riley Brigit | Chief Scientific Officer | Mar 15, 2023 | Sale | $0.78 | 7,299 | 5,705 | 117,435 | Mar 17, 2023, 06:02 PM |
| Soparkar Peter | Chief Operating Officer | Mar 15, 2023 | Sale | $0.78 | 13,360 | 10,442 | 265,891 | Mar 17, 2023, 06:02 PM |
| Fischer Laurent | CEO, President and Director | Mar 15, 2023 | Sale | $0.78 | 41,239 | 32,232 | 692,141 | Mar 17, 2023, 06:01 PM |
| Beckman Richard | Chief Medical Officer | Sep 19, 2022 | Sale | $1.07 | 4,272 | 4,570 | 39,061 | Sep 21, 2022, 08:01 PM |
| Seyedkazemi Setareh | Chief Development Officer | Sep 19, 2022 | Sale | $1.07 | 6,058 | 6,480 | 47,875 | Sep 21, 2022, 08:00 PM |
| Soparkar Peter | See Remarks section | Sep 19, 2022 | Sale | $1.07 | 13,305 | 14,232 | 273,251 | Sep 21, 2022, 07:59 PM |
| Riley Brigit | Chief Scientific Officer | Sep 19, 2022 | Sale | $1.07 | 7,266 | 7,772 | 118,734 | Sep 21, 2022, 07:58 PM |
| Fischer Laurent | CEO, President and Director | Sep 19, 2022 | Sale | $1.07 | 41,082 | 43,941 | 727,380 | Sep 21, 2022, 07:57 PM |
| Seyedkazemi Setareh | Chief Development Officer | May 23, 2022 | Buy | $0.84 | 20,000 | 16,800 | 20,600 | May 24, 2022, 04:47 PM |
| Beckman Richard | Chief Medical Officer | May 17, 2022 | Buy | $0.82 | 10,000 | 8,228 | 10,000 | May 19, 2022, 07:43 PM |
| Svoronos Dawn | Director | May 16, 2022 | Buy | $0.85 | 30,000 | 25,578 | 50,000 | May 18, 2022, 04:43 PM |
| D'Souza Rupert | Chief Financial Officer | May 17, 2022 | Buy | $0.83 | 10,000 | 8,272 | 20,850 | May 17, 2022, 06:28 PM |
| D'Souza Rupert | Chief Financial Officer | May 13, 2022 | Buy | $0.86 | 10,000 | 8,585 | 10,850 | May 17, 2022, 06:28 PM |
| Fischer Laurent | CEO, President and Director | Apr 20, 2022 | Buy | $1.11 | 25,000 | 27,800 | 762,462 | Apr 22, 2022, 05:00 PM |
| Soparkar Peter | See Remarks section | Apr 19, 2022 | Buy | $1.14 | 21,925 | 24,994 | 280,556 | Apr 20, 2022, 04:35 PM |
| Fischer Laurent | CEO, President and Director | Dec 09, 2021 | Buy | $1.85 | 14,323 | 26,498 | 737,462 | Dec 10, 2021, 05:26 PM |
| Fischer Laurent | CEO, President and Director | Dec 08, 2021 | Buy | $1.79 | 10,677 | 19,112 | 723,139 | Dec 10, 2021, 05:26 PM |
| Soparkar Peter | See Remarks section | Dec 08, 2021 | Buy | $1.91 | 25,000 | 47,750 | 258,631 | Dec 10, 2021, 05:26 PM |
| Scopa James Paul | Director | Nov 15, 2021 | Sale | $2.18 | 50,000 | 109,000 | 3,334 | Nov 17, 2021, 04:38 PM |
| Clark Julie | Chief Medical Officer | Sep 30, 2021 | Sale | $2.17 | 4,766 | 10,342 | 164,723 | Oct 04, 2021, 05:36 PM |
| Svoronos Dawn | Director | Mar 31, 2021 | Buy | $10.02 | 20,000 | 200,338 | 20,000 | Apr 01, 2021, 08:21 PM |
| Fischer Laurent | CEO and Director | Mar 24, 2021 | Buy | $9.88 | 10,000 | 98,780 | 26,292 | Mar 24, 2021, 07:47 PM |
| Machado Patrick | Director | Mar 24, 2021 | Buy | $9.92 | 10,000 | 99,196 | 88,182 | Mar 24, 2021, 07:46 PM |
| PATTERSON LEONE D | President and CFO | Feb 09, 2021 | Sale | $14.10 | 12,533 | 176,718 | 98,017 | Feb 11, 2021, 07:47 PM |
| Machado Patrick | Director | Jan 15, 2021 | Buy | $11.52 | 10,000 | 115,174 | 78,182 | Jan 19, 2021, 08:33 PM |
| Fischer Laurent | CEO and Director | Jan 15, 2021 | Buy | $11.53 | 8,600 | 99,191 | 16,292 | Jan 19, 2021, 08:32 PM |
| Soparkar Peter | Chief Legal Officer | Aug 17, 2020 | Buy | $13.00 | 7,692 | 99,996 | 10,692 | Aug 19, 2020, 06:48 PM |
| Fischer Laurent | CEO and Director | Aug 17, 2020 | Buy | $13.00 | 7,692 | 99,996 | 7,692 | Aug 19, 2020, 06:45 PM |
| Gasmi Mehdi | Director | Jul 20, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 279,442 | Jul 22, 2020, 09:44 PM |
| Gasmi Mehdi | Director | Jul 20, 2020 | Sale | $17.60 | 5,000 | 87,978 | 274,442 | Jul 22, 2020, 09:44 PM |
| Gasmi Mehdi | Director | Jun 22, 2020 | Option Exercise | $4.80 | 23,605 | 113,304 | 298,047 | Jun 23, 2020, 06:58 PM |
| Gasmi Mehdi | Director | Jun 22, 2020 | Sale | $25.06 | 23,605 | 591,617 | 274,442 | Jun 23, 2020, 06:58 PM |
| Gasmi Mehdi | Director | Jun 18, 2020 | Option Exercise | $4.80 | 11,127 | 53,410 | 285,569 | Jun 18, 2020, 09:45 PM |
| Gasmi Mehdi | Director | Jun 17, 2020 | Option Exercise | $4.80 | 268 | 1,286 | 274,710 | Jun 18, 2020, 09:45 PM |
| Gasmi Mehdi | Director | Jun 17, 2020 | Sale | $25.01 | 268 | 6,703 | 274,442 | Jun 18, 2020, 09:45 PM |
| Gasmi Mehdi | Director | Jun 18, 2020 | Sale | $25.01 | 11,127 | 278,329 | 274,442 | Jun 18, 2020, 09:45 PM |
| PATTERSON LEONE D | President | Jun 16, 2020 | Sale | $24.68 | 13,171 | 325,060 | 110,488 | Jun 17, 2020, 05:47 PM |
| Gasmi Mehdi | Director | Jun 15, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | Jun 17, 2020, 05:14 PM |
| Gasmi Mehdi | Director | Jun 15, 2020 | Sale | $21.86 | 10,000 | 218,627 | 279,442 | Jun 17, 2020, 05:14 PM |
| Gasmi Mehdi | Director | May 21, 2020 | Option Exercise | $4.80 | 3,599 | 17,275 | 278,041 | May 22, 2020, 06:55 PM |
| Gasmi Mehdi | Director | May 20, 2020 | Option Exercise | $4.80 | 1,401 | 6,725 | 275,843 | May 22, 2020, 06:55 PM |
| Gasmi Mehdi | Director | May 20, 2020 | Sale | $20.01 | 1,401 | 28,030 | 274,442 | May 22, 2020, 06:55 PM |
| Gasmi Mehdi | Director | May 21, 2020 | Sale | $20.02 | 3,599 | 72,048 | 274,442 | May 22, 2020, 06:55 PM |
| Gasmi Mehdi | Director | May 06, 2020 | Option Exercise | $4.80 | 25,000 | 120,000 | 299,442 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | May 05, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | May 18, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 279,442 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | May 05, 2020 | Sale | $16.26 | 10,000 | 162,573 | 274,442 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | May 18, 2020 | Sale | $18.17 | 5,000 | 90,833 | 274,742 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | May 06, 2020 | Sale | $20.03 | 25,000 | 500,667 | 274,442 | May 20, 2020, 07:34 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $12.56 | 46,976 | 589,876 | 289,936 | May 20, 2020, 07:33 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 284,442 | May 20, 2020, 07:33 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $15.07 | 10,000 | 150,690 | 274,442 | May 20, 2020, 07:33 PM |
| PATTERSON LEONE D | CEO, President and Director | May 06, 2020 | Option Exercise | $3.44 | 20,000 | 68,800 | 143,659 | May 08, 2020, 06:25 PM |
| PATTERSON LEONE D | CEO, President and Director | May 06, 2020 | Sale | $20.02 | 20,000 | 400,400 | 123,659 | May 08, 2020, 06:25 PM |
| PATTERSON LEONE D | CEO, President and Director | Feb 09, 2020 | Option Exercise | $10.24 | 10,985 | 112,486 | 139,235 | May 08, 2020, 06:24 PM |
| Scopa James Paul | Director | May 04, 2020 | Option Exercise | $6.48 | 23,334 | 151,204 | 53,334 | May 05, 2020, 06:44 PM |
| PATTERSON LEONE D | CEO, President and Director | Mar 20, 2020 | Option Exercise | $3.44 | 24,424 | 84,019 | 162,955 | Mar 25, 2020, 05:28 PM |
| PATTERSON LEONE D | CEO, President and Director | Mar 20, 2020 | Sale | $10.17 | 39,526 | 401,908 | 123,429 | Mar 25, 2020, 05:28 PM |
| PATTERSON LEONE D | CEO, President and Director | Mar 17, 2020 | Sale | $10.02 | 474 | 4,749 | 138,531 | Mar 18, 2020, 07:33 PM |
| Gasmi Mehdi | Director | Feb 18, 2020 | Option Exercise | $4.80 | 5,000 | 24,000 | 263,979 | Feb 20, 2020, 04:51 PM |
| Gasmi Mehdi | Director | Feb 18, 2020 | Sale | $16.23 | 5,000 | 81,156 | 258,979 | Feb 20, 2020, 04:51 PM |
| Scopa James Paul | Director | Feb 14, 2020 | Buy | $13.75 | 10,000 | 137,500 | 30,000 | Feb 14, 2020, 08:58 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $12.56 | 46,945 | 589,525 | 289,967 | Feb 14, 2020, 08:57 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Option Exercise | $4.80 | 10,000 | 48,000 | 268,979 | Feb 14, 2020, 08:57 PM |
| Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $15.07 | 10,000 | 150,690 | 258,979 | Feb 14, 2020, 08:57 PM |
| Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 15,494 | 158,659 | 274,473 | Feb 14, 2020, 08:55 PM |
| Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 11,551 | 118,282 | 309,867 | Feb 10, 2020, 07:57 AM |
| PATTERSON LEONE D | CEO, President and Director | Feb 09, 2020 | Option Exercise | $10.24 | 11,215 | 114,842 | 139,005 | Feb 10, 2020, 07:56 AM |
| PATTERSON LEONE D | CEO, President and Director | Dec 23, 2019 | Sale | $10.72 | 40,000 | 428,800 | 150,220 | Feb 10, 2020, 07:54 AM |
| Gasmi Mehdi | Director | Feb 12, 2019 | Option Exercise | $3.55 | 10,652 | 37,815 | 322,007 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Feb 12, 2017 | Option Exercise | $3.00 | 12,793 | 38,379 | 276,742 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Feb 09, 2019 | Option Exercise | $3.33 | 12,599 | 41,955 | 332,659 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Apr 21, 2018 | Option Exercise | $6.30 | 605 | 3,812 | 247,762 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Feb 12, 2018 | Option Exercise | $6.85 | 10,806 | 74,021 | 248,367 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Feb 09, 2018 | Option Exercise | $7.05 | 11,433 | 80,603 | 259,173 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Aug 21, 2017 | Option Exercise | $2.50 | 5,479 | 13,698 | 270,606 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Apr 21, 2019 | Option Exercise | $5.98 | 589 | 3,522 | 321,418 | Feb 10, 2020, 07:52 AM |
| Gasmi Mehdi | Director | Apr 21, 2017 | Option Exercise | $2.70 | 657 | 1,774 | 276,085 | Feb 10, 2020, 07:52 AM |
| PATTERSON LEONE D | CEO, President and Director | Jun 15, 2019 | Option Exercise | $10.82 | 43,852 | 474,479 | 225,502 | Feb 10, 2020, 07:51 AM |
| PATTERSON LEONE D | CEO, President and Director | Feb 09, 2019 | Option Exercise | $3.33 | 8,176 | 27,226 | 234,072 | Feb 10, 2020, 07:51 AM |
| PATTERSON LEONE D | CEO, President and Director | Jun 15, 2018 | Option Exercise | $5.55 | 8,645 | 47,980 | 242,248 | Feb 10, 2020, 07:51 AM |
| PATTERSON LEONE D | CEO, President and Director | Feb 09, 2018 | Option Exercise | $7.05 | 8,208 | 57,866 | 162,397 | Feb 10, 2020, 07:51 AM |
| PATTERSON LEONE D | CEO, President and Director | Jun 15, 2017 | Option Exercise | $2.70 | 9,395 | 25,367 | 170,605 | Feb 10, 2020, 07:51 AM |
| PATTERSON LEONE D | CEO, President and Director | Dec 23, 2019 | Sale | $10.72 | 40,000 | 428,800 | 228,496 | Dec 26, 2019, 04:47 PM |
| Scopa James Paul | Director | May 06, 2019 | Buy | $6.71 | 20,000 | 134,200 | 20,000 | May 06, 2019, 07:42 PM |
| Gasmi Mehdi | SVP,Pharmaceutical Development | Jun 15, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 17, 2015, 08:33 PM |
| Gasmi Mehdi | SVP,Pharmaceutical Development | Jun 15, 2015 | Sale | $39.86 | 500 | 19,931 | 7,000 | Jun 17, 2015, 08:33 PM |
| Wachter Paul | Director | Jun 15, 2015 | Sale | $39.86 | 1,192 | 47,516 | 37,161 | Jun 17, 2015, 08:33 PM |
| Schwartz Steven Daniel | Director | Jun 15, 2015 | Sale | $39.86 | 16,875 | 672,671 | 367,931 | Jun 17, 2015, 08:33 PM |
| Hull Hans | SVP, Business Operations | Jun 12, 2015 | Option Exercise | $0.19 | 8,300 | 1,577 | 19,620 | Jun 16, 2015, 06:25 PM |
| Blumenkranz Mark S. | Director | Jun 11, 2015 | Sale | $39.97 | 1,900 | 75,939 | 522,989 | Jun 15, 2015, 05:01 PM |
| Bain Linda | Chief Financial Officer | Jun 12, 2015 | Option Exercise | $3.15 | 3,500 | 11,025 | 12,500 | Jun 15, 2015, 05:00 PM |
| Bain Linda | Chief Financial Officer | Jun 12, 2015 | Sale | $39.94 | 3,500 | 139,795 | 9,000 | Jun 15, 2015, 05:00 PM |
| GUERIN JOHN PATRICK ET AL | Director | Jun 10, 2015 | Sale | $206.00 | 699 | 143,994 | 150,000 | Jun 11, 2015, 09:09 PM |
| GUERIN JOHN PATRICK ET AL | Director | May 28, 2015 | Sale | $208.00 | 1 | 208 | 150,699 | Jun 11, 2015, 09:09 PM |
| GUERIN JOHN PATRICK ET AL | Director | May 27, 2015 | Sale | $206.00 | 1,205 | 248,230 | 150,700 | Jun 11, 2015, 09:09 PM |
| Blumenkranz Mark S. | Director | Jun 10, 2015 | Sale | $39.91 | 600 | 23,948 | 524,889 | Jun 11, 2015, 06:21 PM |
| Blumenkranz Mark S. | Director | Jun 09, 2015 | Sale | $35.75 | 22,500 | 804,328 | 532,689 | Jun 11, 2015, 06:21 PM |
| Chalberg Thomas W. | Chief Executive Officer | Jun 10, 2015 | Sale | $38.05 | 25,000 | 951,194 | 278,953 | Jun 11, 2015, 06:21 PM |
| Wachter Paul | Director | Jun 08, 2015 | Sale | $38.64 | 1,192 | 46,061 | 39,004 | Jun 10, 2015, 08:29 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Jun 08, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 10, 2015, 08:28 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Jun 08, 2015 | Sale | $38.64 | 500 | 19,321 | 7,265 | Jun 10, 2015, 08:28 PM |
| Blumenkranz Mark S. | Director | Jun 05, 2015 | Sale | $40.08 | 5,000 | 200,414 | 547,989 | Jun 08, 2015, 05:20 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | Jun 05, 2015, 08:00 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Sale | $38.02 | 500 | 19,009 | 7,000 | Jun 05, 2015, 08:00 PM |
| Hull Hans | SVP, Business Operations | Jun 04, 2015 | Option Exercise | $0.19 | 2,000 | 380 | 13,320 | Jun 05, 2015, 05:59 PM |
| Hull Hans | SVP, Business Operations | Jun 04, 2015 | Sale | $37.64 | 2,000 | 75,283 | 11,320 | Jun 05, 2015, 05:59 PM |
| Wachter Paul | Director | Jun 01, 2015 | Sale | $36.23 | 1,192 | 43,191 | 39,755 | Jun 02, 2015, 08:24 PM |
| Schwartz Steven Daniel | Director | Jun 01, 2015 | Sale | $36.23 | 17,250 | 625,043 | 387,899 | Jun 02, 2015, 08:24 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 29, 2015, 02:37 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Sale | $38.02 | 500 | 19,009 | 7,000 | May 29, 2015, 02:37 PM |
| Wachter Paul | Director | May 26, 2015 | Sale | $36.94 | 1,192 | 44,037 | 41,143 | May 27, 2015, 06:39 PM |
| Schwartz Steven Daniel | Director | May 22, 2015 | Sale | $38.38 | 16,875 | 647,687 | 407,252 | May 22, 2015, 07:21 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 21, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 22, 2015, 04:36 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 21, 2015 | Sale | $38.87 | 500 | 19,435 | 7,000 | May 22, 2015, 04:36 PM |
| Blumenkranz Mark S. | Director | May 19, 2015 | Sale | $36.91 | 3,000 | 110,734 | 10,531 | May 21, 2015, 05:53 PM |
| Wachter Paul | Director | May 18, 2015 | Sale | $35.31 | 1,192 | 42,086 | 41,929 | May 19, 2015, 06:24 PM |
| Blumenkranz Mark S. | Director | May 15, 2015 | Sale | $35.49 | 22,500 | 798,553 | 557,514 | May 18, 2015, 05:22 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 14, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 15, 2015, 05:47 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 14, 2015 | Sale | $35.31 | 500 | 17,656 | 7,000 | May 15, 2015, 05:47 PM |
| Blumenkranz Mark S. | Director | May 13, 2015 | Sale | $34.94 | 715 | 24,984 | 575,489 | May 13, 2015, 07:16 PM |
| Bain Linda | Chief Financial Officer | May 13, 2015 | Option Exercise | $3.15 | 285 | 898 | 9,285 | May 13, 2015, 07:15 PM |
| Bain Linda | Chief Financial Officer | May 13, 2015 | Sale | $34.94 | 285 | 9,959 | 9,000 | May 13, 2015, 07:15 PM |
| Wachter Paul | Director | May 11, 2015 | Sale | $33.38 | 1,192 | 39,792 | 43,805 | May 12, 2015, 05:05 PM |
| Bain Linda | Chief Financial Officer | May 11, 2015 | Option Exercise | $3.15 | 715 | 2,252 | 9,715 | May 12, 2015, 05:03 PM |
| Bain Linda | Chief Financial Officer | May 11, 2015 | Sale | $34.91 | 715 | 24,964 | 9,000 | May 12, 2015, 05:03 PM |
| Blumenkranz Mark S. | Director | May 11, 2015 | Sale | $34.91 | 1,785 | 62,323 | 576,204 | May 12, 2015, 05:00 PM |
| Schwartz Steven Daniel | Director | May 08, 2015 | Sale | $33.05 | 17,250 | 570,092 | 418,931 | May 11, 2015, 05:00 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 07, 2015 | Option Exercise | $2.75 | 500 | 1,375 | 7,500 | May 08, 2015, 07:09 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | May 07, 2015 | Sale | $33.28 | 500 | 16,638 | 7,000 | May 08, 2015, 07:09 PM |
| Chalberg Thomas W. | Chief Executive Officer | May 05, 2015 | Sale | $30.00 | 25,000 | 750,093 | 283,988 | May 07, 2015, 04:16 PM |
| Hull Hans | SVP, Business Operations | May 04, 2015 | Option Exercise | $0.19 | 5,000 | 950 | 16,320 | May 06, 2015, 04:06 PM |
| Hull Hans | SVP, Business Operations | May 04, 2015 | Sale | $30.87 | 5,000 | 154,349 | 11,320 | May 06, 2015, 04:06 PM |
| Bain Linda | Chief Financial Officer | May 04, 2015 | Option Exercise | $3.15 | 2,500 | 7,875 | 11,500 | May 06, 2015, 04:06 PM |
| Bain Linda | Chief Financial Officer | May 04, 2015 | Sale | $31.59 | 2,500 | 78,972 | 9,000 | May 06, 2015, 04:06 PM |
| Wachter Paul | Director | May 04, 2015 | Sale | $30.87 | 1,192 | 36,797 | 44,313 | May 06, 2015, 04:05 PM |
| Blumenkranz Mark S. | Director | May 01, 2015 | Sale | $32.37 | 20,000 | 647,306 | 577,989 | May 05, 2015, 04:06 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 28, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 8,000 | Apr 30, 2015, 06:51 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 28, 2015 | Sale | $35.67 | 1,000 | 35,667 | 7,000 | Apr 30, 2015, 06:51 PM |
| Wachter Paul | Director | Apr 27, 2015 | Sale | $35.61 | 1,192 | 42,443 | 45,505 | Apr 29, 2015, 05:47 PM |
| Schwartz Steven Daniel | Director | Apr 23, 2015 | Sale | $38.62 | 16,875 | 651,665 | 436,181 | Apr 23, 2015, 07:52 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 21, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 1,000 | Apr 23, 2015, 04:58 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 21, 2015 | Sale | $39.21 | 1,000 | 39,211 | 0 | Apr 23, 2015, 04:58 PM |
| Wachter Paul | Director | Apr 20, 2015 | Sale | $40.19 | 1,192 | 47,910 | 46,697 | Apr 21, 2015, 05:49 PM |
| Blumenkranz Mark S. | Director | Apr 16, 2015 | Sale | $41.59 | 25,000 | 1,039,753 | 596,189 | Apr 20, 2015, 05:37 PM |
| Zygtech, LLC | 10% Owner | Apr 14, 2015 | Sale | $39.93 | 4,600 | 183,663 | 2,438,176 | Apr 15, 2015, 05:25 PM |
| Zygtech, LLC | 10% Owner | Apr 13, 2015 | Sale | $39.46 | 20,400 | 805,009 | 2,450,902 | Apr 15, 2015, 05:25 PM |
| Wachter Paul | Director | Apr 13, 2015 | Sale | $39.34 | 1,192 | 46,896 | 48,251 | Apr 15, 2015, 05:25 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 14, 2015 | Option Exercise | $2.75 | 1,000 | 2,750 | 1,000 | Apr 15, 2015, 05:24 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 14, 2015 | Sale | $39.45 | 1,000 | 39,448 | 0 | Apr 15, 2015, 05:24 PM |
| Schwartz Steven Daniel | Director | Apr 09, 2015 | Sale | $39.73 | 17,250 | 685,278 | 451,256 | Apr 13, 2015, 04:47 PM |
| Blumenkranz Mark S. | Director | Apr 07, 2015 | Sale | $38.60 | 3,000 | 115,808 | 11,563 | Apr 08, 2015, 04:47 PM |
| Blumenkranz Mark S. | Director | Apr 08, 2015 | Sale | $39.94 | 2,500 | 99,841 | 620,989 | Apr 08, 2015, 04:47 PM |
| Blumenkranz Mark S. | Director | Apr 07, 2015 | Sale | $38.60 | 22,500 | 868,560 | 624,215 | Apr 08, 2015, 04:47 PM |
| Hull Hans | SVP, Business Operations | Apr 07, 2015 | Option Exercise | $0.19 | 27,500 | 5,225 | 30,820 | Apr 08, 2015, 04:32 PM |
| Hull Hans | SVP, Business Operations | Apr 07, 2015 | Sale | $38.60 | 27,500 | 1,061,573 | 4,207 | Apr 08, 2015, 04:32 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 07, 2015 | Option Exercise | $2.75 | 9,000 | 24,750 | 9,000 | Apr 08, 2015, 04:29 PM |
| Gasmi Mehdi | VP, Pharmaceutical Development | Apr 07, 2015 | Sale | $38.60 | 9,000 | 347,425 | 292 | Apr 08, 2015, 04:29 PM |
| Zygtech, LLC | 10% Owner | Jan 13, 2015 | Sale | $55.46 | 100,000 | 5,546,000 | 2,463,176 | Jan 15, 2015, 05:00 PM |
| Wachter Paul | Director | Jan 13, 2015 | Sale | $55.46 | 14,000 | 776,440 | 49,081 | Jan 15, 2015, 04:59 PM |
| Schwartz Steven Daniel | Director | Jan 13, 2015 | Sale | $55.46 | 91,000 | 5,046,860 | 468,306 | Jan 15, 2015, 04:58 PM |
| Chalberg Thomas W. | Chief Executive Officer | Jan 13, 2015 | Sale | $55.46 | 85,000 | 4,714,100 | 285,988 | Jan 15, 2015, 04:58 PM |
| Blumenkranz Mark S. | Director | Jan 13, 2015 | Sale | $55.46 | 100,000 | 5,546,000 | 645,989 | Jan 15, 2015, 04:57 PM |
| Chalberg Thomas W. | Chief Executive Officer | Dec 12, 2014 | Option Exercise | $0.21 | 413 | 87 | 371,401 | Jan 14, 2015, 05:43 PM |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 400,000 | 6,800,000 | 2,365,471 | Aug 07, 2014, 03:18 PM |
| Venrock Associates VI, L.P. | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 400,000 | 6,800,000 | 2,365,471 | Aug 07, 2014, 03:17 PM |
| Schwartz Steven Daniel | Director | Aug 05, 2014 | Option Exercise | $0.15 | 34,000 | 5,100 | 534,000 | Aug 07, 2014, 03:11 PM |
| Blumenkranz Mark S. | Director | Aug 05, 2014 | Option Exercise | $0.15 | 25,000 | 3,750 | 725,000 | Aug 07, 2014, 03:07 PM |
| REGENERON PHARMACEUTICALS INC | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 588,235 | 9,999,995 | 1,809,098 | Aug 05, 2014, 05:39 PM |
| Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $25.14 | 507,200 | 12,752,446 | 507,200 | Aug 05, 2014, 05:26 PM |
| Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 123,077 | 2,092,309 | 654,285 | Aug 05, 2014, 05:26 PM |
| Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 34,223 | 581,791 | 181,633 | Aug 05, 2014, 05:26 PM |
| Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $17.00 | 42,700 | 725,900 | 227,294 | Aug 05, 2014, 05:26 PM |
| Flynn James E | 10% Owner | Aug 05, 2014 | Buy | $25.14 | 627,267 | 15,770,984 | 627,267 | Aug 05, 2014, 05:26 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Scopa James Paul | Director | 02/07/2024 | 135,000 |
| Lupher, Jr. Mark L. | Director | 02/07/2024 | 175,500 |
| Seyedkazemi Setareh | Chief Development Officer | 09/15/2023 | 9,429 |
| Rubinstein Linda M | Chief Financial Officer | 06/07/2023 | 145,490 |
| Riley Brigit | Chief Scientific Officer | 03/15/2023 | 5,705 |
| Soparkar Peter | Chief Operating Officer | 03/15/2023 | 10,442 |
| Fischer Laurent | CEO, President and Director | 03/15/2023 | 32,232 |
| Beckman Richard | Chief Medical Officer | 09/19/2022 | 4,570 |
| Seyedkazemi Setareh | Chief Development Officer | 09/19/2022 | 6,480 |
| Soparkar Peter | See Remarks section | 09/19/2022 | 14,232 |
| Riley Brigit | Chief Scientific Officer | 09/19/2022 | 7,772 |
| Fischer Laurent | CEO, President and Director | 09/19/2022 | 43,941 |
| Seyedkazemi Setareh | Chief Development Officer | 05/23/2022 | 16,800 |
| Beckman Richard | Chief Medical Officer | 05/17/2022 | 8,228 |
| Svoronos Dawn | Director | 05/16/2022 | 25,578 |
| D'Souza Rupert | Chief Financial Officer | 05/17/2022 | 8,272 |
| D'Souza Rupert | Chief Financial Officer | 05/13/2022 | 8,585 |
| Fischer Laurent | CEO, President and Director | 04/20/2022 | 27,800 |
| Soparkar Peter | See Remarks section | 04/19/2022 | 24,994 |
| Fischer Laurent | CEO, President and Director | 12/09/2021 | 26,498 |
| Fischer Laurent | CEO, President and Director | 12/08/2021 | 19,112 |
| Soparkar Peter | See Remarks section | 12/08/2021 | 47,750 |
| Scopa James Paul | Director | 11/15/2021 | 109,000 |
| Clark Julie | Chief Medical Officer | 09/30/2021 | 10,342 |
| Svoronos Dawn | Director | 03/31/2021 | 200,338 |
| Fischer Laurent | CEO and Director | 03/24/2021 | 98,780 |
| Machado Patrick | Director | 03/24/2021 | 99,196 |
| PATTERSON LEONE D | President and CFO | 02/09/2021 | 176,718 |
| Machado Patrick | Director | 01/15/2021 | 115,174 |
| Fischer Laurent | CEO and Director | 01/15/2021 | 99,191 |
| Soparkar Peter | Chief Legal Officer | 08/17/2020 | 99,996 |
| Fischer Laurent | CEO and Director | 08/17/2020 | 99,996 |
| Gasmi Mehdi | Director | 07/20/2020 | 24,000 |
| Gasmi Mehdi | Director | 07/20/2020 | 87,978 |
| Gasmi Mehdi | Director | 06/22/2020 | 113,304 |
| Gasmi Mehdi | Director | 06/22/2020 | 591,617 |
| Gasmi Mehdi | Director | 06/18/2020 | 53,410 |
| Gasmi Mehdi | Director | 06/17/2020 | 1,286 |
| Gasmi Mehdi | Director | 06/17/2020 | 6,703 |
| Gasmi Mehdi | Director | 06/18/2020 | 278,329 |
| PATTERSON LEONE D | President | 06/16/2020 | 325,060 |
| Gasmi Mehdi | Director | 06/15/2020 | 48,000 |
| Gasmi Mehdi | Director | 06/15/2020 | 218,627 |
| Gasmi Mehdi | Director | 05/21/2020 | 17,275 |
| Gasmi Mehdi | Director | 05/20/2020 | 6,725 |
| Gasmi Mehdi | Director | 05/20/2020 | 28,030 |
| Gasmi Mehdi | Director | 05/21/2020 | 72,048 |
| Gasmi Mehdi | Director | 05/06/2020 | 120,000 |
| Gasmi Mehdi | Director | 05/05/2020 | 48,000 |
| Gasmi Mehdi | Director | 05/18/2020 | 24,000 |
| Gasmi Mehdi | Director | 05/05/2020 | 162,573 |
| Gasmi Mehdi | Director | 05/18/2020 | 90,833 |
| Gasmi Mehdi | Director | 05/06/2020 | 500,667 |
| Gasmi Mehdi | Director | 02/12/2020 | 589,876 |
| Gasmi Mehdi | Director | 02/12/2020 | 48,000 |
| Gasmi Mehdi | Director | 02/12/2020 | 150,690 |
| PATTERSON LEONE D | CEO, President and Director | 05/06/2020 | 68,800 |
| PATTERSON LEONE D | CEO, President and Director | 05/06/2020 | 400,400 |
| PATTERSON LEONE D | CEO, President and Director | 02/09/2020 | 112,486 |
| Scopa James Paul | Director | 05/04/2020 | 151,204 |
| PATTERSON LEONE D | CEO, President and Director | 03/20/2020 | 84,019 |
| PATTERSON LEONE D | CEO, President and Director | 03/20/2020 | 401,908 |
| PATTERSON LEONE D | CEO, President and Director | 03/17/2020 | 4,749 |
| Gasmi Mehdi | Director | 02/18/2020 | 24,000 |
| Gasmi Mehdi | Director | 02/18/2020 | 81,156 |
| Scopa James Paul | Director | 02/14/2020 | 137,500 |
| Gasmi Mehdi | Director | 02/12/2020 | 589,525 |
| Gasmi Mehdi | Director | 02/12/2020 | 48,000 |
| Gasmi Mehdi | Director | 02/12/2020 | 150,690 |
| Gasmi Mehdi | Director | 02/09/2020 | 158,659 |
| Gasmi Mehdi | Director | 02/09/2020 | 118,282 |
| PATTERSON LEONE D | CEO, President and Director | 02/09/2020 | 114,842 |
| PATTERSON LEONE D | CEO, President and Director | 12/23/2019 | 428,800 |
| Gasmi Mehdi | Director | 02/12/2019 | 37,815 |
| Gasmi Mehdi | Director | 02/12/2017 | 38,379 |
| Gasmi Mehdi | Director | 02/09/2019 | 41,955 |
| Gasmi Mehdi | Director | 04/21/2018 | 3,812 |
| Gasmi Mehdi | Director | 02/12/2018 | 74,021 |
| Gasmi Mehdi | Director | 02/09/2018 | 80,603 |
| Gasmi Mehdi | Director | 08/21/2017 | 13,698 |
| Gasmi Mehdi | Director | 04/21/2019 | 3,522 |
| Gasmi Mehdi | Director | 04/21/2017 | 1,774 |
| PATTERSON LEONE D | CEO, President and Director | 06/15/2019 | 474,479 |
| PATTERSON LEONE D | CEO, President and Director | 02/09/2019 | 27,226 |
| PATTERSON LEONE D | CEO, President and Director | 06/15/2018 | 47,980 |
| PATTERSON LEONE D | CEO, President and Director | 02/09/2018 | 57,866 |
| PATTERSON LEONE D | CEO, President and Director | 06/15/2017 | 25,367 |
| PATTERSON LEONE D | CEO, President and Director | 12/23/2019 | 428,800 |
| Scopa James Paul | Director | 05/06/2019 | 134,200 |
| Gasmi Mehdi | SVP,Pharmaceutical Development | 06/15/2015 | 1,375 |
| Gasmi Mehdi | SVP,Pharmaceutical Development | 06/15/2015 | 19,931 |
| Wachter Paul | Director | 06/15/2015 | 47,516 |
| Schwartz Steven Daniel | Director | 06/15/2015 | 672,671 |
| Hull Hans | SVP, Business Operations | 06/12/2015 | 1,577 |
| Blumenkranz Mark S. | Director | 06/11/2015 | 75,939 |
| Bain Linda | Chief Financial Officer | 06/12/2015 | 11,025 |
| Bain Linda | Chief Financial Officer | 06/12/2015 | 139,795 |
| GUERIN JOHN PATRICK ET AL | Director | 06/10/2015 | 143,994 |
| GUERIN JOHN PATRICK ET AL | Director | 05/28/2015 | 208 |
| GUERIN JOHN PATRICK ET AL | Director | 05/27/2015 | 248,230 |
| Blumenkranz Mark S. | Director | 06/10/2015 | 23,948 |
| Blumenkranz Mark S. | Director | 06/09/2015 | 804,328 |
| Chalberg Thomas W. | Chief Executive Officer | 06/10/2015 | 951,194 |
| Wachter Paul | Director | 06/08/2015 | 46,061 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 06/08/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 06/08/2015 | 19,321 |
| Blumenkranz Mark S. | Director | 06/05/2015 | 200,414 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 19,009 |
| Hull Hans | SVP, Business Operations | 06/04/2015 | 380 |
| Hull Hans | SVP, Business Operations | 06/04/2015 | 75,283 |
| Wachter Paul | Director | 06/01/2015 | 43,191 |
| Schwartz Steven Daniel | Director | 06/01/2015 | 625,043 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/28/2015 | 19,009 |
| Wachter Paul | Director | 05/26/2015 | 44,037 |
| Schwartz Steven Daniel | Director | 05/22/2015 | 647,687 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/21/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/21/2015 | 19,435 |
| Blumenkranz Mark S. | Director | 05/19/2015 | 110,734 |
| Wachter Paul | Director | 05/18/2015 | 42,086 |
| Blumenkranz Mark S. | Director | 05/15/2015 | 798,553 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/14/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/14/2015 | 17,656 |
| Blumenkranz Mark S. | Director | 05/13/2015 | 24,984 |
| Bain Linda | Chief Financial Officer | 05/13/2015 | 898 |
| Bain Linda | Chief Financial Officer | 05/13/2015 | 9,959 |
| Wachter Paul | Director | 05/11/2015 | 39,792 |
| Bain Linda | Chief Financial Officer | 05/11/2015 | 2,252 |
| Bain Linda | Chief Financial Officer | 05/11/2015 | 24,964 |
| Blumenkranz Mark S. | Director | 05/11/2015 | 62,323 |
| Schwartz Steven Daniel | Director | 05/08/2015 | 570,092 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/07/2015 | 1,375 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 05/07/2015 | 16,638 |
| Chalberg Thomas W. | Chief Executive Officer | 05/05/2015 | 750,093 |
| Hull Hans | SVP, Business Operations | 05/04/2015 | 950 |
| Hull Hans | SVP, Business Operations | 05/04/2015 | 154,349 |
| Bain Linda | Chief Financial Officer | 05/04/2015 | 7,875 |
| Bain Linda | Chief Financial Officer | 05/04/2015 | 78,972 |
| Wachter Paul | Director | 05/04/2015 | 36,797 |
| Blumenkranz Mark S. | Director | 05/01/2015 | 647,306 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/28/2015 | 2,750 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/28/2015 | 35,667 |
| Wachter Paul | Director | 04/27/2015 | 42,443 |
| Schwartz Steven Daniel | Director | 04/23/2015 | 651,665 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/21/2015 | 2,750 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/21/2015 | 39,211 |
| Wachter Paul | Director | 04/20/2015 | 47,910 |
| Blumenkranz Mark S. | Director | 04/16/2015 | 1,039,753 |
| Zygtech, LLC | 10% Owner | 04/14/2015 | 183,663 |
| Zygtech, LLC | 10% Owner | 04/13/2015 | 805,009 |
| Wachter Paul | Director | 04/13/2015 | 46,896 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/14/2015 | 2,750 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/14/2015 | 39,448 |
| Schwartz Steven Daniel | Director | 04/09/2015 | 685,278 |
| Blumenkranz Mark S. | Director | 04/07/2015 | 115,808 |
| Blumenkranz Mark S. | Director | 04/08/2015 | 99,841 |
| Blumenkranz Mark S. | Director | 04/07/2015 | 868,560 |
| Hull Hans | SVP, Business Operations | 04/07/2015 | 5,225 |
| Hull Hans | SVP, Business Operations | 04/07/2015 | 1,061,573 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/07/2015 | 24,750 |
| Gasmi Mehdi | VP, Pharmaceutical Development | 04/07/2015 | 347,425 |
| Zygtech, LLC | 10% Owner | 01/13/2015 | 5,546,000 |
| Wachter Paul | Director | 01/13/2015 | 776,440 |
| Schwartz Steven Daniel | Director | 01/13/2015 | 5,046,860 |
| Chalberg Thomas W. | Chief Executive Officer | 01/13/2015 | 4,714,100 |
| Blumenkranz Mark S. | Director | 01/13/2015 | 5,546,000 |
| Chalberg Thomas W. | Chief Executive Officer | 12/12/2014 | 87 |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 08/05/2014 | 6,800,000 |
| Venrock Associates VI, L.P. | 10% Owner | 08/05/2014 | 6,800,000 |
| Schwartz Steven Daniel | Director | 08/05/2014 | 5,100 |
| Blumenkranz Mark S. | Director | 08/05/2014 | 3,750 |
| REGENERON PHARMACEUTICALS INC | 10% Owner | 08/05/2014 | 9,999,995 |
| Flynn James E | 10% Owner | 08/05/2014 | 12,752,446 |
| Flynn James E | 10% Owner | 08/05/2014 | 2,092,309 |
| Flynn James E | 10% Owner | 08/05/2014 | 581,791 |
| Flynn James E | 10% Owner | 08/05/2014 | 725,900 |
| Flynn James E | 10% Owner | 08/05/2014 | 15,770,984 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ADVERUM BIOTECHNOLOGIES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,877,652 | 0.00219% | 41.2% | Other |
| VIVO CAPITAL, LLC | 1,500,000 | 1.67% | New | Other |
| BLACKROCK INC. | 1,401,180 | 0.00003% | -0.00771% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 864,206 | 0.00007% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR ADVERUM BIOTECHNOLOGIES INC
STOCK BUYBACKS FOR ADVERUM BIOTECHNOLOGIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.45%
2Q
03/31/2023
0.91%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.75%
5Q
06/30/2022
2.24%
6Q
03/31/2022
2.66%
7Q
12/31/2021
3.01%
8Q
09/30/2021
3.15%
9Q
06/30/2021
3.26%
10Q
03/31/2021
3.55%
11Q
12/31/2020
3.71%
12Q
09/30/2020
13.90%
13Q
06/30/2020
26.16%
14Q
03/31/2020
37.16%
15Q
12/31/2019
55.44%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ADVERUM BIOTECHNOLOGIES INC
LOADING...